Lolita the whale may someday return to wild, Miami park says, but timeline uncertain

But the move isn’t a done deal, and veterinarians and trainers told WPLG in Miami this week that they’re working with Lolita to make sure she’s strong enough to survive the journey and to acclimate to her new home.

More News

Pentavalent Vaccine Candidate for Meningitis Makes Its Case

In a randomized trial conducted in the African meningitis belt, an investigational pentavalent meningococcal vaccine proved safe and with noninferior immunogenicity to a licensed quadrivalent product,

Nearly 5M Target candles recalled due to consumer injury reports

About 4.9 million Target candles were recalled on Thursday, after six people reported injuries, according to the U.S. Consumer Product Safety Commission (CPSC). The Threshold candles, which

How the end of the COVID-19 public health emergency is impacting people

The Groton nursing and independent living facility Fairview posted a video a week and a half ago in which nurses removed their masks in unison, threw them into the air graduation-ceremony style, and shouted,

COVID public health emergency is over: Here's what it means for you

The government officially ended the COVID-19 Public Health Emergency (PHE) on May 11. Now that the public health emergency is officially over, how will things change?

Widely viewed video alleges safety concerns at UAB hospital

The TikTok video said UAB hospital had problems in the sterile processing department that cleans surgical instruments, creating hazards for employees and patients. A hospital spokesman denied the allegations.

Mother of 8-year-old girl who died in Border Patrol custody says pleas for hospital care ...

The mother of an 8-year-old girl who died in Border Patrol custody said Friday that agents repeatedly ignored pleas to hospitalize her medically fragile daughter as she felt

Ocaliva for NASH Gets Thumbs Down From FDA Advisors

On Friday, the Gastrointestinal Drugs Advisory Committee voted 12-2 (with two abstentions) that the improvements in liver scarring seen in the pivotal REGENERATE trial with a 25-mg dose of obeticholic acid do not outweigh the various risks,

.

.